TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33100818

Group type: EXPERIMENTAL
Intervention: Electrostatic Precipitation (EP) during laparoscopic hysterectomy
Number of subjects: 35

Group type: COMPARATOR
Intervention: No Electrostatic Precipitation (No EP) during laparoscopic hysterectomy
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Electrostatic Precipitation (EP)
Number of subjects: 35

Group type: COMPARATOR
Intervention: No Electrostatic Precipitation (No EP)
Number of subjects: 35
Study: 34986562

Group type: EXPERIMENTAL
Intervention: Biochar amendment at 1%
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Biochar amendment at 3%
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Lead toxicity at 400 mg kg‐1
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Lead toxicity at 1200 mg kg‐1
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control (0 mg kg‐1 lead)
Number of subjects: 3
Study: 32831969

Group type: EXPERIMENTAL
Intervention: Conversational therapy through VR
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional therapy (CT)
Number of subjects: 36
Study: 33784196

Group type: EXPERIMENTAL
Intervention: Control-IQ technology
Number of subjects: 9451
Study: 34081197

Group type: EXPERIMENTAL
Intervention: Arthroscopic‐assisted latissimus dorsi transfer alone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Arthroscopic‐assisted latissimus dorsi transfer with partial cuff repair
Number of subjects: 15
Study: 33900918

Group type: COMPARATOR
Intervention: 3D Convolutional Neural Network (CNN) using effective connectivity (EC) matrices from EEG recordings of AUD patients and healthy controls.
Number of subjects: 62

Group type: COMPARATOR
Intervention: 3D Convolutional Neural Network (CNN) for binary classification of AUD cases.
Number of subjects: 62
Study: 33067494

Group type: EXPERIMENTAL
Intervention: Completely randomized (CR) design
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Randomised block (RB) design
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: General experimental designs
Number of subjects: 100
Study: 35840886

Group type: EXPERIMENTAL
Intervention: 0.75 Hz tACS
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 42
Study: 34938292

Group type: EXPERIMENTAL
Intervention: Chemotherapy on day 1 and toripalimab on day 3 (experimental group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Chemotherapy and toripalimab on day 1 (control group)
Number of subjects: 30
Study: 35284377

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS) based on independent risk factors
Number of subjects: 27073

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting CSS
Number of subjects: 27073
Study: 32726228

Group type: EXPERIMENTAL
Intervention: Pulsatile flow
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonpulsatile flow
Number of subjects: 40
Study: 34479189

Group type: EXPERIMENTAL
Intervention: Supercharged motor nerve transfer via a 5‐cm incision following decompression and anterior subfascial transposition
Number of subjects: 93

Group type: COMPARATOR
Intervention: Decompression and anterior subfascial transposition alone
Number of subjects: 93
Study: 33894131

Group type: EXPERIMENTAL
Intervention: suvratoxumab 5000 mg
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study: 33798730

Group type: EXPERIMENTAL
Intervention: Communication coaching intervention provided by a communication coach who reviews recorded patient encounters and gives tailored feedback.
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 400
Study: 36361437

Group type: EXPERIMENTAL
Intervention: Intervention group (received spirometry results and smoking cessation advice)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Control group (received only smoking cessation advice)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 350
Study: 32556249

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral-Based Physical Therapy (CBPT)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Education program
Number of subjects: 86
Study: 35590102

Group type: EXPERIMENTAL
Intervention: Transcanalicular laser dacryocystorhinostomy (TCL‐DCR) with endonasal augmentation (Group 1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Transcanalicular laser dacryocystorhinostomy (TCL‐DCR) with endonasal augmentation after 10 days (Group 2)
Number of subjects: 90

Group type: COMPARATOR
Intervention: External DCR (Group 3)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study: 33674821

Group type: EXPERIMENTAL
Intervention: Concealed opioid reduction
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard tapering
Number of subjects: 74
Study: 34853932

Group type: EXPERIMENTAL
Intervention: Topical aloe vera extract gel applied thrice daily for 2 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-level laser therapy (LLLT) at 980 nm twice weekly for 2 months
Number of subjects: 60
Study: 34810347

Group type: EXPERIMENTAL
Intervention: Kidodent mouthwash
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Probiotics mouthwash
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: C. papaya leaf extract mouthwash
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo mouthwash (distilled water)
Number of subjects: 60
Study: 35412220

Group type: EXPERIMENTAL
Intervention: AMG 986 tablet formulation
Number of subjects: 12

Group type: COMPARATOR
Intervention: AMG 986 capsule formulation
Number of subjects: 12
Study: 34166843

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D supplementation
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Early prenatal vitamin D insufficiency with late sufficiency
Number of subjects: 414
Study: 34407895

Group type: EXPERIMENTAL
Intervention: Whey Protein (WP) - 40 g concentrated WP
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hydrolysed Collagen - 40 g
Number of subjects: 10
Study: 34146143

Group type: EXPERIMENTAL
Intervention: intermittent TBS (iTBS) to the left and continuous TBS (cTBS) to the right dlPFC
Number of subjects: 236

Group type: COMPARATOR
Intervention: bilateral sham stimulation
Number of subjects: 236
Study: 32949918

Group type: EXPERIMENTAL
Intervention: High-protein meal (HP; 30 g protein, 17 g fat, 52 g carbohydrate)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Low-protein meal (LP; 13 g protein, 25 g fat, 54 g carbohydrate)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: High-protein meal (HP)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Low-protein meal (LP)
Number of subjects: 31
Study: 35980648

Group type: EXPERIMENTAL
Intervention: Individualized management combined with drug treatment (silver ion alginate, hydrocolloid dressing, foam dressing)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Drug treatment (silver ion alginate, hydrocolloid dressing, foam dressing)
Number of subjects: 60
Study: 34382590

Group type: EXPERIMENTAL
Intervention: Local injection combined with mouth opening training for 2 years
Number of subjects: 220

Group type: COMPARATOR
Intervention: Local injection of Salvia miltiorrhiza and triamcinolone acetonide, once a week, 8 times a course
Number of subjects: 220
Study: 35764955

Group type: EXPERIMENTAL
Intervention: 500 mg AEO BID
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 1000 mg AEO BID
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 1000 mg AEO TID
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 500 mg AEO BID (Long COVID)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 1000 mg AEO (Long COVID)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Historical placebo
Number of subjects: 119
Study: 33417346

Group type: EXPERIMENTAL
Intervention: Active neurostimulation device
Number of subjects: 52

Group type: COMPARATOR
Intervention: Inactive (sham) device
Number of subjects: 52
Study: 33026304

Group type: EXPERIMENTAL
Intervention: Inoculation with Aspergillus niger isolates An-1 and An-2 on surface-disinfected leaves of MLT.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (unwounded leaves inoculated with An-1 and An-2).
Number of subjects: 100
Study: 35156893

Group type: EXPERIMENTAL
Intervention: Donor-FMT
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo FMT
Number of subjects: 83
Study: 32602555

Group type: COMPARATOR
Intervention: Historical placebo data
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current approaches to historical controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed path forward
Number of subjects: 0
Study: 35964170

Group type: EXPERIMENTAL
Intervention: Ultrasound (US) therapy (15 sessions)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT) (9 sessions)
Number of subjects: 60
Study: 33517038

Group type: EXPERIMENTAL
Intervention: High‐Intensity Functional Exercise (HIFE) program targeting lower limb strength, balance and mobility exercise
Number of subjects: 186

Group type: COMPARATOR
Intervention: Seated attention control activity
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: High‐Intensity Functional Exercise (HIFE) program
Number of subjects: 186
Study: 33087406

Group type: EXPERIMENTAL
Intervention: Cognitive aid
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (without cognitive aid)
Number of subjects: 100
Study: 35818187

Group type: EXPERIMENTAL
Intervention: Pelvic IMRT in combination with chemotherapy (Taxol and Carboplatin)
Number of subjects: 114

Group type: COMPARATOR
Intervention: 3D-CRT in combination with chemotherapy (Taxol and Carboplatin)
Number of subjects: 114
Study: 32266567

Group type: EXPERIMENTAL
Intervention: Dentoxol mouthrinse 5 times/day
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control mouthrinse
Number of subjects: 108
Study: 35218006

Group type: EXPERIMENTAL
Intervention: Telephone-based cognitive behavioral therapy (Tele-CBT)
Number of subjects: 81
Study: 32690536

Group type: EXPERIMENTAL
Intervention: Oral suvorexant (20 mg) once daily starting the night after extubation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 34247463

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation follow-up program
Number of subjects: 33
Study: 35202552

Group type: EXPERIMENTAL
Intervention: Diesel Exhaust (DE) exposure
Number of subjects: 30

Group type: COMPARATOR
Intervention: Filtered Air (Control)
Number of subjects: 30
Study: 32610115

Group type: EXPERIMENTAL
Intervention: MSDC-0602K
Number of subjects: 339
Study: 32533085

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham (incomplete inflation of the blood-pressure cuff)
Number of subjects: 22
Study: 35488711

Group type: EXPERIMENTAL
Intervention: Diet + Visceral Manipulation (VM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-calorie diet
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Diet + VM
Number of subjects: 30
Study: 32956551

Group type: COMPARATOR
Intervention: Spontaneous Healing (SH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DBBM-CM (without immediate implant placement)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IMPL/DBBM-CM (with immediate implant placement)
Number of subjects: 0
Study: 35840087

Group type: EXPERIMENTAL
Intervention: Ixazomib (3 mg, days 1, 8, 15)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 34533091

Group type: EXPERIMENTAL
Intervention: Free-range larvae
Number of subjects: 54

Group type: COMPARATOR
Intervention: Larval-bag
Number of subjects: 54
Study: 35447566

Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy with carbogen breathing and nicotinamide (ARCON)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Accelerated radiotherapy (AR)
Number of subjects: 44
Study: 34369940

Group type: EXPERIMENTAL
Intervention: Red wine exposure (25 mL rinsed four times a day during bleaching)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no red wine)
Number of subjects: 80
Study: 36374159

Group type: EXPERIMENTAL
Intervention: Amoxicillin-containing BQT (bismuth potassium citrate 110 mg four times/day, esomeprazole 20 mg twice daily, metronidazole 400 mg four times/day, amoxicillin 500 mg four times/day)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Tetracycline-containing BQT (tetracycline 500 mg four times/day, bismuth potassium citrate 110 mg four times/day, esomeprazole 20 mg twice daily, metronidazole 400 mg four times/day)
Number of subjects: 404
Study: 34897105

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with gemcitabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 33565206

Group type: EXPERIMENTAL
Intervention: Mesenchymal stromal cell (MSC) therapy with early tacrolimus withdrawal
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control tacrolimus group
Number of subjects: 57
Study: 35670262

Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA) group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total sleep deprivation group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: REM sleep deprivation group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 0
Study: 33433720

Group type: EXPERIMENTAL
Intervention: Isotretinoin 20 mg/daily + cryotherapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Cryotherapy only
Number of subjects: 46
Study: 32385057

Group type: EXPERIMENTAL
Intervention: Serum levels of 4,137 proteins
Number of subjects: 5438

Group type: EXPERIMENTAL
Intervention: Subset of observed protein associations
Number of subjects: 5438

Group type: EXPERIMENTAL
Intervention: Bi-directional two-sample Mendelian randomization analysis
Number of subjects: 5438
Study: 36450541

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 164
Study: 33263170

Group type: EXPERIMENTAL
Intervention: Oral Sucrosomial iron
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous sodium ferrigluconate
Number of subjects: 0
Study: 34539392

Group type: EXPERIMENTAL
Intervention: Favipiravir (1600 mg*2 on the first day followed by 600 mg*2/day for 7 days)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Arbidol (200 mg*3/day for 7 days)
Number of subjects: 240
Study: 35927622

Group type: EXPERIMENTAL
Intervention: 12-week group exercise program with three counselling visits to physiotherapists over 9 months
Number of subjects: 119

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 119
Study: 34278887

Group type: EXPERIMENTAL
Intervention: Linzagolix (75-200 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Linzagolix (dose not specified)
Number of subjects: 0
Study: 34601163

Group type: EXPERIMENTAL
Intervention: Periarticular multidrug injection (PMDI)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Epidural catheter (EC)
Number of subjects: 55
Study: 35372959

Group type: EXPERIMENTAL
Intervention: Multifaceted, evidence-based intervention aimed at reducing HD-CRBSI
Number of subjects: 3615

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 3615
Study: 35165113

Group type: EXPERIMENTAL
Intervention: ProLife intervention (three brief motivational interviewing sessions and SMS messages)
Number of subjects: 574

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 574

Group type: EXPERIMENTAL
Intervention: ProLife intervention
Number of subjects: 574
Study: 34325579

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (daily exercise including radio gymnastics and Jianxincao)
Number of subjects: 32
Study: 35182846

Group type: EXPERIMENTAL
Intervention: Early tracheostomy (ET)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard tracheostomy (ST)
Number of subjects: 39
Study: 34686129

Group type: EXPERIMENTAL
Intervention: Email delivery method
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Hybrid delivery method
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Regular mail delivery method
Number of subjects: 602
Study: 32292074

Group type: EXPERIMENTAL
Intervention: 1.8 mg liraglutide daily
Number of subjects: 241

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 241
Study: 35676450

Group type: EXPERIMENTAL
Intervention: TQ‐Z2301 (40 mg subcutaneously every other week for 24 weeks)
Number of subjects: 380

Group type: COMPARATOR
Intervention: adalimumab (subcutaneously every other week for 24 weeks)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: TQ‐Z2301
Number of subjects: 380

Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: TQ‐Z2301 and adalimumab
Number of subjects: 380
Study: 33500114

Group type: EXPERIMENTAL
Intervention: Ultra-Processed Food (UPF) intake at 12 months
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Ultra-Processed Food (UPF) intake at 24 months
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Ultra-Processed Food (UPF) intake at 60 months
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Correlation of UPF intake between 24 and 60 months
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Demographic factors associated with UPF intake
Number of subjects: 669
Study: 32067149

Group type: EXPERIMENTAL
Intervention: Low-dose droperidol (median dose 21 µg/kg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Baseline motor‐evoked potential values
Number of subjects: 34
Study: 33244559

Group type: EXPERIMENTAL
Intervention: Encouragement to spend time outdoors for 20-30 minutes daily for two months during summer
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 35065281

Group type: EXPERIMENTAL
Intervention: Supervised 12-month intensive multimodal exercise intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderate aerobic exercise intervention
Number of subjects: 0
Study: 33927212

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask (LM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Laryngeal Tube (LT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: I-GEL
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Video Laryngoscopy (VL)
Number of subjects: 20
Study: 33040331

Group type: EXPERIMENTAL
Intervention: Individual patient data analysis
Number of subjects: 526
Study: 32184056

Group type: EXPERIMENTAL
Intervention: ED‐PN (Patient Navigation program)
Number of subjects: 100

Group type: COMPARATOR
Intervention: UC (Usual Care)
Number of subjects: 100
Study: 33188692

Group type: EXPERIMENTAL
Intervention: Multi-catheter cryotherapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Radiofrequency (RF) ablation
Number of subjects: 100
Study: 616025870

Group type: EXPERIMENTAL
Intervention: Pneumatic Trabeculoplasty (PNT)
Number of subjects: 23
Study: 34651606

Group type: EXPERIMENTAL
Intervention: Islatravir 5 mg, once daily for 42 days
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Islatravir 0.25 mg, once daily for 28 days
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Islatravir 0.75 mg, once daily for 28 days
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Islatravir (all doses)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Islatravir (0.25 mg)
Number of subjects: 36
Study: 34651612

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) at 95% of peak power output
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Moderate Intensity Continuous Training (MICT) at 50% of peak power output
Number of subjects: 10

Group type: COMPARATOR
Intervention: Both HIIT and MICT
Number of subjects: 10
Study: 35534823

Group type: EXPERIMENTAL
Intervention: Heat stress
Number of subjects: 6
Study: 33167956

Group type: EXPERIMENTAL
Intervention: Area based stratified random sampling using GIS
Number of subjects: 217
Study: 34861745

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block with saline peri-articular injection
Number of subjects: 62

Group type: COMPARATOR
Intervention: Peri-articular injection with saline erector spinae plane block
Number of subjects: 62
Study: 32063238

Group type: EXPERIMENTAL
Intervention: Simple reminiscence intervention program (10 weekly sessions lasting 2 hours each)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 139
Study: 32987943

Group type: EXPERIMENTAL
Intervention: Riceberry rice yogurt (350 g with 0.25% riceberry rice extract)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Riceberry rice yogurt
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control yogurt
Number of subjects: 19
Study: 35952766

Group type: EXPERIMENTAL
Intervention: Home-based strength training program (IG)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 123
Study: 33336530

Group type: EXPERIMENTAL
Intervention: Chlorhexidine swabstick
Number of subjects: 44

Group type: COMPARATOR
Intervention: Silver nitrate
Number of subjects: 44
Study: 32027918

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention (n=2848)
Number of subjects: 7110

Group type: COMPARATOR
Intervention: Diet-only intervention
Number of subjects: 7110

Group type: COMPARATOR
Intervention: Physical activity-only intervention
Number of subjects: 7110

Group type: COMPARATOR
Intervention: Control group (n=2808)
Number of subjects: 7110
Study: 34352857

Group type: EXPERIMENTAL
Intervention: Oxygen administration (75.4% of interventions)
Number of subjects: 2251

Group type: EXPERIMENTAL
Intervention: Oxygen administration (subgroup with absent FHR accelerations and absent-minimal FHR variability, n=332)
Number of subjects: 2251

Group type: EXPERIMENTAL
Intervention: Oxygen administration (subgroup with FHR accelerations or moderate FHR variability, n=1,919)
Number of subjects: 2251

Group type: EXPERIMENTAL
Intervention: Overall improvement to category I within 60 minutes
Number of subjects: 2251

Group type: EXPERIMENTAL
Intervention: Improvement to category I within 60 minutes (n=1,433)
Number of subjects: 2251

Group type: EXPERIMENTAL
Intervention: No improvement within 60 minutes (n=818)
Number of subjects: 2251

Group type: EXPERIMENTAL
Intervention: Improvement to category I within 60 minutes
Number of subjects: 2251

Group type: EXPERIMENTAL
Intervention: Overall incidence of composite neonatal adverse outcome for category II tracings
Number of subjects: 2251
Study: 32599496

Group type: EXPERIMENTAL
Intervention: NADA acupuncture
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 72

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 72